BIOSPECIFICS TECHNOLOGIES CORP Debt Securities, Held-to-maturity, Current
BIOSPECIFICS TECHNOLOGIES CORP had Debt Securities, Held-to-maturity, Current of $83.84 million as of 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:HeldToMaturitySecuritiesCurrent · last filed 2020-11-09
- 2020-09-30: Debt Securities, Held-to-maturity, Current $83.84M.
- 2020-06-30: Debt Securities, Held-to-maturity, Current $82.18M.
- 2020-03-31: Debt Securities, Held-to-maturity, Current $85.08M.
- 2019-12-31: Debt Securities, Held-to-maturity, Current $84.24M.
| Period end | Debt Securities, Held-to-maturity, Current |
|---|---|
| 2020-09-30 | $83.84M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $82.18M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $85.08M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $84.24M 10-Q · filed 2020-11-09 |
| 2019-09-30 | $69.09M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $71.30M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $66.90M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $67.71M 10-K · filed 2020-03-16 |
| 2018-09-30 | $58.43M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $53.59M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $48.75M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $51.97M 10-K · filed 2019-04-02 |
| 2017-09-30 | $48.17M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $45.12M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $38.84M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $44.25M 10-K · filed 2018-03-14 |
| 2016-09-30 | $45.08M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $36.61M 10-Q · filed 2016-08-09 |
| 2015-12-31 | $28.35M 10-K · filed 2017-03-16 |
| 2014-12-31 | $10.90M 10-K · filed 2016-03-14 |
| 2013-12-31 | $6.97M 10-K · filed 2015-03-16 |